Source: |
Type: |
NLRP3 (NOD-like receptor pyrin domain-containing protein 3) is a protein that plays a crucial role in the regulation of inflammation and immune responses. NLRP3 typically has high expression in cancers, with poor prognosis. For alzheimer's disease: -NLRP3 is upregulated in Alzheimer's disease (AD) -NLRP3 is activated in microglia in response to amyloid-β (Aβ) and tau aggregates. -Promotes tau hyperphosphorylation and spread via inflammation-driven pathways. |
2434- | 2DG, | Inhibition of Key Glycolytic Enzyme Hexokinase 2 Ameliorates Psoriasiform Inflammation in vitro and in vivo |
- | in-vitro, | PSA, | NA | - | in-vivo, | PSA, | NA |
2661- | AL, | Allicin alleviates traumatic brain injury-induced neuroinflammation by enhancing PKC-δ-mediated mitophagy |
- | in-vivo, | Nor, | NA |
4280- | Api, | Protective effects of apigenin in neurodegeneration: An update on the potential mechanisms |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3393- | ART/DHA, | Artemisinin-derived artemisitene blocks ROS-mediated NLRP3 inflammasome and alleviates ulcerative colitis |
- | in-vivo, | Col, | NA |
3164- | Ash, | Withaferin A alleviates fulminant hepatitis by targeting macrophage and NLRP3 |
3519- | Bor, | Boron-Based Inhibitors of the NLRP3 Inflammasome |
- | Review, | NA, | NA |
4263- | CA, | Neuroprotective Effects of Carnosic Acid: Insight into Its Mechanisms of Action |
- | Review, | AD, | NA |
2398- | CGA, | Polyphenol-rich diet mediates interplay between macrophage-neutrophil and gut microbiota to alleviate intestinal inflammation |
- | in-vivo, | Col, | NA |
1418- | CUR, | Potential complementary and/or synergistic effects of curcumin and boswellic acids for management of osteoarthritis |
- | Review, | Arthritis, | NA |
3795- | CUR, | Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence |
- | Review, | AD, | NA |
3224- | EGCG, | Epigallocatechin-3-Gallate Prevents Acute Gout by Suppressing NLRP3 Inflammasome Activation and Mitochondrial DNA Synthesis |
- | in-vitro, | Nor, | NA |
3225- | EGCG, | Epigallocatechin‐3‐Gallate Ameliorates Diabetic Kidney Disease by Inhibiting the TXNIP/NLRP3/IL‐1β Signaling Pathway |
- | in-vitro, | Nor, | NA | - | in-vivo, | Nor, | NA |
3783- | FA, | Design, Synthesis, and Biological Evaluation of Ferulic Acid-Piperazine Derivatives Targeting Pathological Hallmarks of Alzheimer’s Disease |
- | NA, | AD, | NA |
3714- | FA, | Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer's Disease: A Narrative Review |
- | Review, | AD, | NA |
3778- | FA, | Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer’s Disease: A Narrative Review |
- | Review, | AD, | NA |
854- | Gra, | SNP, | Green Synthesis of Silver Nanoparticles Using Annona muricata Extract as an Inducer of Apoptosis in Cancer Cells and Inhibitor for NLRP3 Inflammasome via Enhanced Autophagy |
- | vitro+vivo, | AML, | THP1 | - | in-vitro, | AML, | AMJ13 | - | vitro+vivo, | lymphoma, | HBL |
2508- | H2, | Molecular hydrogen is a promising therapeutic agent for pulmonary disease |
- | Review, | Var, | NA | - | Review, | Sepsis, | NA |
3787- | H2, | Hydrogen, a Novel Therapeutic Molecule, Regulates Oxidative Stress, Inflammation, and Apoptosis |
- | Review, | AD, | NA |
3776- | H2, | The role of hydrogen in Alzheimer's disease |
- | Review, | AD, | NA |
3774- | H2, | The role of hydrogen in Alzheimer’s disease |
- | Review, | AD, | NA |
3773- | H2, | Role and mechanism of molecular hydrogen in the treatment of Parkinson’s diseases |
- | Review, | Park, | NA |
3770- | H2, | Role of Molecular Hydrogen in Ageing and Ageing-Related Diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3766- | H2, | The role of hydrogen in Alzheimer′s disease |
- | Review, | AD, | NA |
3767- | H2, | The role of hydrogen therapy in Alzheimer's disease management: Insights into mechanisms, administration routes, and future challenges |
- | Review, | AD, | NA |
4345- | H2, | The Benefit of Hydrogen Gas as an Adjunctive Therapy for Chronic Obstructive Pulmonary Disease |
- | Human, | NA, | NA |
3769- | H2S, | Research progress of hydrogen sulfide in Alzheimer's disease from laboratory to hospital: a narrative review |
- | Review, | AD, | NA |
2919- | LT, | Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence |
- | Review, | Var, | NA |
2921- | LT, | Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies |
- | Review, | Nor, | NA |
3265- | Lyco, | Lycopene inhibits pyroptosis of endothelial progenitor cells induced by ox-LDL through the AMPK/mTOR/NLRP3 pathway |
- | in-vitro, | Nor, | NA |
3472- | MF, | NLRP3Caspase1GSDMD_signaling_path">Pulsed electromagnetic field alleviates synovitis and inhibits the NLRP3/Caspase-1/GSDMD signaling pathway in osteoarthritis rats |
- | in-vivo, | ostP, | NA |
3471- | MF, | The prevention effect of pulsed electromagnetic fields treatment on senile osteoporosis in vivo via improving the inflammatory bone microenvironment |
- | in-vivo, | Nor, | NA |
3850- | MSM, | The Influence of Methylsulfonylmethane on Inflammation-Associated Cytokine Release before and following Strenuous Exercise |
- | Human, | NA, | NA |
3847- | MSM, | Methylsulfonylmethane: Applications and Safety of a Novel Dietary Supplement |
- | Review, | Arthritis, | NA |
3810- | mushLions, | Key Mechanisms and Potential Implications of Hericium erinaceus in NLRP3 Inflammasome Activation by Reactive Oxygen Species during Alzheimer’s Disease |
- | Review, | NA, | NA |
4035- | NAD, | VitB3, | NAD+ supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING |
- | in-vitro, | AD, | NA |
2056- | PB, | Endoplasmic Reticulum Stress Induces ROS Production and Activates NLRP3 Inflammasome Via the PERK-CHOP Signaling Pathway in Dry Eye Disease |
- | in-vitro, | Nor, | HCE-2 |
2381- | PBG, | Chinese Poplar Propolis Inhibits MDA-MB-231 Cell Proliferation in an Inflammatory Microenvironment by Targeting Enzymes of the Glycolytic Pathway |
- | in-vitro, | BC, | MDA-MB-231 |
2961- | PL, | Piperlongumine inhibits esophageal squamous cell carcinoma in vitro and in vivo by triggering NRF2/ROS/TXNIP/NLRP3-dependent pyroptosis |
- | in-vitro, | ESCC, | KYSE-30 |
2972- | PL, | Piperlongumine Is an NLRP3 Inhibitor With Anti-inflammatory Activity |
- | in-vitro, | AML, | THP1 |
2996- | PL, | Application of longinamide in inhibiting the activation of NLRP3 inflammasome |
- | NA, | AD, | NA | - | NA, | Park, | NA |
3931- | PTS, | Pterostilbene Protects against Osteoarthritis through NLRP3 Inflammasome Inactivation and Improves Gut Microbiota as Evidenced by In Vivo and In Vitro Studies |
- | in-vivo, | Arthritis, | NA |
3924- | PTS, | Effect of resveratrol and pterostilbene on aging and longevity |
- | Review, | AD, | NA | - | Review, | Stroke, | NA |
3918- | PTS, | Pterostilbene inhibits amyloid-β-induced neuroinflammation in a microglia cell line by inactivating the NLRP3/caspase-1 inflammasome pathway |
- | in-vitro, | AD, | BV2 |
2339- | QC, | Quercetin protects against LPS-induced lung injury in mice via SIRT1-mediated suppression of PKM2 nuclear accumulation |
- | in-vivo, | Nor, | NA |
2338- | QC, | Quercetin: A Flavonoid with Potential for Treating Acute Lung Injury |
- | Review, | Nor, | NA |
3347- | QC, | Recent Advances in Potential Health Benefits of Quercetin |
- | Review, | Var, | NA | - | Review, | AD, | NA |
4297- | QC, | Quercetin attenuates tau hyperphosphorylation and improves cognitive disorder via suppression of ER stress in a manner dependent on AMPK pathway |
- | in-vitro, | AD, | SH-SY5Y |
3069- | RES, | Resveratrol Inhibits NLRP3 Inflammasome-Induced Pyroptosis and miR-155 Expression in Microglia Through Sirt1/AMPK Pathway |
- | in-vitro, | Nor, | N9 |
3070- | RES, | Resveratrol inhibits tumor progression by down-regulation of NLRP3 in renal cell carcinoma |
- | in-vitro, | RCC, | ACHN | - | in-vitro, | RCC, | 786-O | - | in-vivo, | NA, | NA |
3071- | RES, | Resveratrol and Its Anticancer Effects |
- | Review, | Var, | NA |
3072- | RES, | Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway |
- | in-vitro, | GBM, | LN229 | - | in-vitro, | GBM, | U87MG |
3073- | RES, | Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy |
- | in-vitro, | Nor, | NA |
3074- | RES, | Possible therapeutic targets for NLRP3 inflammasome-induced breast cancer |
- | Review, | BC, | NA |
3075- | RES, | Rad, | The Protection Effect of Resveratrol Against Radiation-Induced Inflammatory Bowel Disease via NLRP-3 Inflammasome Repression in Mice |
- | in-vivo, | Nor, | NA |
3079- | RES, | Therapeutic role of resveratrol against hepatocellular carcinoma: A review on its molecular mechanisms of action |
- | Review, | Var, | NA |
4286- | RES, | Neuroprotective Properties of Resveratrol and Its Derivatives—Influence on Potential Mechanisms Leading to the Development of Alzheimer’s Disease |
- | Review, | AD, | NA |
3615- | RosA, | Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer's Disease, Parkinson's Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3018- | RosA, | Rosemary (Rosmarinus officinalis L.) polyphenols and inflammatory bowel diseases: Major phytochemicals, functional properties, and health effects |
- | Review, | IBD, | NA |
3003- | RosA, | Comprehensive Insights into Biological Roles of Rosmarinic Acid: Implications in Diabetes, Cancer and Neurodegenerative Diseases |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
3008- | RosA, | Rosmarinic acid decreases viability, inhibits migration and modulates expression of apoptosis-related CASP8/CASP3/NLRP3 genes in human metastatic melanoma cells |
- | in-vitro, | Melanoma, | SK-MEL-28 |
3657- | SFN, | Sulforaphane exerts its anti-inflammatory effect against amyloid-β peptide via STAT-1 dephosphorylation and activation of Nrf2/HO-1 cascade in human THP-1 macrophages |
- | NA, | AD, | THP1 |
3658- | SFN, | Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer’s Disease |
- | Review, | AD, | NA |
3186- | SFN, | A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet |
- | in-vivo, | Nor, | NA |
3185- | SFN, | Sulforaphane decreases oxidative stress and inhibits NLRP3 inflammasome activation in a mouse model of ulcerative colitis |
- | in-vivo, | Nor, | RAW264.7 |
3324- | SIL, | Silymarin prevents NLRP3 inflammasome activation and protects against intracerebral hemorrhage |
3331- | SIL, | The clinical anti-inflammatory effects and underlying mechanisms of silymarin |
- | Review, | NA, | NA |
3330- | SIL, | Mechanistic Insights into the Pharmacological Significance of Silymarin |
- | Review, | Var, | NA |
2354- | SK, | PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation |
- | in-vivo, | Sepsis, | NA |
3418- | TQ, | Thymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3 inflammasome |
- | in-vitro, | Melanoma, | A375 | - | in-vivo, | NA, | NA |
3419- | TQ, | Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients |
- | in-vitro, | BC, | NA |
3420- | TQ, | Thymoquinone alleviates the accumulation of ROS and pyroptosis and promotes perforator skin flap survival through SIRT1/NF-κB pathway |
- | in-vitro, | Nor, | HUVECs | - | in-vitro, | NA, | NA |
2119- | TQ, | Dual properties of Nigella Sativa: anti-oxidant and pro-oxidant |
- | Review, | Var, | NA |
3125- | VitC, | Vitamin C inhibits NLRP3 inflammasome activation and delays the development of age-related hearing loss in male C57BL/6 mice |
- | in-vivo, | Nor, | NA |
3126- | VitC, | Safety of High-Dose Vitamin C in Non-Intensive Care Hospitalized Patients with COVID-19: An Open-Label Clinical Study |
- | Study, | NA, | NA |
3127- | VitC, | NLRP3_inflammasome_by_scavenging_mitochondrial_ROS">Vitamin C inhibits the activation of the NLRP3 inflammasome by scavenging mitochondrial ROS |
- | in-vitro, | Nor, | NA | - | in-vivo, | Nor, | NA |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:908 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid